BIOMARIN PHARMACEUTICAL INC financial data

Symbol
BMRN on Nasdaq
Location
Novato, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 28 Oct 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 528% % 74%
Quick Ratio 192% % 69%
Debt-to-equity 24% % -28%
Return On Equity 8.8% % 42%
Return On Assets 7.1% % 53%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 192,114,344 shares 0.8%
Common Stock, Shares, Outstanding 192,098,751 shares 0.81%
Entity Public Float $8,700,000,000 USD -14%
Common Stock, Value, Issued $192,000 USD 0.52%
Weighted Average Number of Shares Outstanding, Basic 192,032,000 shares 0.84%
Weighted Average Number of Shares Outstanding, Diluted 192,032,000 shares -2.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $3,094,001,000 USD 12%
Cost of Revenue $577,872,000 USD -0.71%
Research and Development Expense $903,026,000 USD 16%
Costs and Expenses $2,478,506,000 USD 3.2%
Operating Income (Loss) $615,495,000 USD 76%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $679,272,000 USD 74%
Income Tax Expense (Benefit) $158,855,000 USD 130%
Net Income (Loss) Attributable to Parent $520,417,000 USD 61%
Earnings Per Share, Basic 2 USD/shares 60%
Earnings Per Share, Diluted 2 USD/shares 61%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $1,250,108,000 USD 85%
Accounts Receivable, after Allowance for Credit Loss, Current $790,266,000 USD 1.6%
Inventory, Net $1,382,173,000 USD 17%
Other Assets, Current $204,265,000 USD 21%
Assets, Current $3,854,543,000 USD 26%
Deferred Income Tax Assets, Net $1,509,109,000 USD -1.4%
Property, Plant and Equipment, Net $1,038,187,000 USD -0.69%
Operating Lease, Right-of-Use Asset $28,680,000 USD -33%
Intangible Assets, Net (Excluding Goodwill) $233,112,000 USD -11%
Goodwill $196,199,000 USD 0%
Other Assets, Noncurrent $270,781,000 USD 36%
Assets $7,614,868,000 USD 11%
Employee-related Liabilities, Current $177,755,000 USD -11%
Contract with Customer, Liability, Current $1,369,000 USD -70%
Liabilities, Current $798,438,000 USD 12%
Operating Lease, Liability, Noncurrent $30,501,000 USD -20%
Other Liabilities, Noncurrent $163,056,000 USD 28%
Liabilities $1,558,157,000 USD 8.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax $33,937,000 USD -830%
Retained Earnings (Accumulated Deficit) $200,779,000 USD
Stockholders' Equity Attributable to Parent $6,056,711,000 USD 12%
Liabilities and Equity $7,614,868,000 USD 11%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $174,394,000 USD 271%
Net Cash Provided by (Used in) Financing Activities $38,779,000 USD 9.4%
Net Cash Provided by (Used in) Investing Activities $28,238,000 USD -98%
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 192,098,751 shares 0.81%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $105,961,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1,250,108,000 USD 85%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD -100%
Deferred Tax Assets, Valuation Allowance $126,311,000 USD 5.9%
Operating Lease, Liability $37,734,000 USD -19%
Depreciation $46,900,000 USD 2.6%
Payments to Acquire Property, Plant, and Equipment $16,768,000 USD -36%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $481,830,000 USD 50%
Lessee, Operating Lease, Liability, to be Paid $46,782,000 USD -20%
Property, Plant and Equipment, Gross $1,987,843,000 USD 3.8%
Operating Lease, Liability, Current $7,233,000 USD -16%
Lessee, Operating Lease, Liability, to be Paid, Year Two $7,906,000 USD -20%
Lessee, Operating Lease, Liability, to be Paid, Year One $9,116,000 USD -19%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Deferred Income Tax Expense (Benefit) $28,429,000 USD 9875%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $9,048,000 USD -23%
Lessee, Operating Lease, Liability, to be Paid, Year Three $6,937,000 USD -13%
Deferred Tax Assets, Operating Loss Carryforwards $18,585,000 USD -2.3%
Unrecognized Tax Benefits $325,035,000 USD 17%
Lessee, Operating Lease, Liability, to be Paid, Year Four $6,231,000 USD -12%
Amortization of Intangible Assets $24,191,000 USD -50%
Depreciation, Depletion and Amortization $22,069,000 USD -19%
Deferred Tax Assets, Net of Valuation Allowance $1,551,467,000 USD -3.9%
Share-based Payment Arrangement, Expense $186,415,000 USD -8.8%
Interest Expense $17,179,000 USD 8.3%